Schizophrenia is a serious neuropsychiatric disease of uncertain etiology. Previous studies have demonstrated that antibodies to Toxoplasma gondii infection are associated with an increased risk of schizophrenia. The objective of this study was to analyze anti-T. gondii antibodies in 477 Chinese schizophrenia patients using an enzyme-linked immunosorbent assay (ELISA) based on recombinant surface antigen 1 (rSAG1), recombinant bradyzoite antigen 1 (rBAG1) and the soluble tachyzoite antigens (STAg) of T. gondii RH strain. Results showed that among the sero-positives (IgG and/or IgM) for T. gondii infection examined in schizophrenia patients, sero-positive samples for rSAG1, rBAG1 and STAg were 20.5% (98/477), 20.5% (98/477) and 23.5% (112/477) respectively, while compared to 210 blood donors, sero-positive (IgG and/or IgM) samples for these antigens (rSAG1, rBAG1 and STAg) were only 5.7% (12/210), 6.2% (13/210) and 5.7% (12/210), respectively. Furthermore, when IgG antibody reaction in the schizophrenia sera was compared with the rBAG1 and rSAG1, results demonstrated that beside the cases which can be detected by both rSAG1 and rBAG1, some sero-positive for T. gondii in schizophrenia sera can only be detected either by rSAG1 or rBAG1. This phenomenon was also observed in the detection of IgM with rSAG1 and rBAG1. 5.9% (28/477) of cases of schizophrenia which are positive for IgG or IgM by rSAG1 are negative for STAg, while 9.2% (44/477) of the schizophrenia cases which are positive for IgG or IgM by rBAG1 are negative for STAg. Although STAg can also be used to diagnose T. gondii infection from schizophrenia patients, it may not actually indicate the infection as some positive samples may be mistakenly considered to be negative. In conclusion, our results demonstrate that the sero-positive rate for T. gondii in the Chinese schizophrenia patients was higher than blood donors. More importantly, our results provide evidence that the combination of rSAG1 and rBAG1 antigens in the diagnosis of T. gondii infection could closely reflect the actual infection of this parasite in schizophrenia patients.
Introduction
Toxoplasma gondii is distributed worldwide and an obligate intracellular parasite (Boothroyd 2009 ), which appears to have a high serological prevalence in many countries (Pappas et al. 2009 ). Comparatively, however, the prevalence of sero-positive T. gondii antibodies in the Chinese populations has been low. As the report of the first national survey on human parasites in 1982, the average serological positive for T. gondii in the Chinese populations was 5.17% (Cui 2000) . In 2004, however, the report of the second national survey for human parasites displayed that the average prevalence of T. gondii sero-positive in Chinese populations was 7.88%, ranging from 0.55% to 15.09% in 15 provinces , Xu et al. 2005 . These authoritative data indicated that T. gondii infection in the populations of China has significantly increased in *Corresponding author: lsslzr@mail.sysu.edu.cn Min Liu et al. 354 the past two decades. It may be an important reason that the cat population has significantly increased as pets in this country (Liu and Zhang 2006) .
Schizophrenia is a devastating neuropsychiatric disorder of unknown causes, affecting approximately 1% of the adult population in the United States and Europe (Torrey and Yolken 2003) . In China, it was estimated that 7.8 million patients were diagnosed with schizophrenia (http://www.chinanews.com. cn/jk/ysbb/news/2009/04-16/1648652.shtml). Genetic studies in the past decade have identified several specific genes which have been associated with schizophrenia risk in a number of populations around the world (Stefansson et al. 2002 , Mao et al. 2009 , and results from family and twin studies also support that there is a strong genetic component in the onset of schizophrenia (Freedman 2003) . However, epidemiological and neuropathological studies have also demonstrated that many cases of schizophrenia may be associated with environmental factors, such as exposure to infectious agents (Yolken et al. 2001) . Although it is possible that schizophrenia may be caused by many factors, a large number of epidemiological and serological studies have indicated that T. gondii infection has a strong link with schizophrenia Yolken 2003,Torrey et al. 2007) .
Currently, there is a need for a gold standard test for detecting anti-T. gondii antibodies, especially for chronic infection caused by cysts containing bradyzoites. It is well known that T. gondii can be found in two forms in human and in other mammal intermediate hosts. The actively proliferating tachyzoites are usually found in the early, more acute phases of the infection in immune compromised individuals, such as AIDS and organ transplantation patients (Derouin and Pelloux 2008, Fernandes et al. 2009 ). The resting bradyzoites, or tissue cysts, primarily exist in brain and muscle tissues and result in chronic infections, probably as a result of the "immune balance" between host and parasite (Curruthers and Suzuki 2007) . To our knowledge, most of the commercially available kits are constructed with whole tachyzoite extracts of T. gondii RH strain as the diagnostic antigen. There is little evidence to indicate that such kits can effectively detect the chronic infection caused by bradyzoites, although interesting results from Dr. R. Yolken's group in Johns Hopkins University indicate that the serological patterns characteristic of Type I T. gondii infection in mothers is linked to a risk of psychosis among adult offspring (Xiao et al. 2009 ). It is clear that there remains a gap in the available methods for accurate diagnosis and distinction of both chronic and acute infections of T. gondii. Thus it is important to develop an appropriate procedure utilizing antigens found both in bradyzoites and tachyzoites, respectively, for schizophrenia patients infected with this parasite.
Bradyzoite antigen 1 (BAG1) and surface antigen 1 (SAG1) are stage antigens expressed specifically in bradyzoites and tachyzoites of T. gondii, respectively. Recombinant BAG1 (rBAG1) and SAG1 (rSAG1) had been produced and used to detect the sensitivity and specificity in chronic and acute T. gondii infection (Wang et al. 2007 , Wu et al. 2009 .
In this work, the antibodies against rBAG1, rSAG1 and the soluble tachyzoite antigens (STAg) in the sera of schizophrenic patients were evaluated comparatively to identify a robust approach to detection of the parasite. Meanwhile, antibodies that are related to the stage antigens will also be likely to provide further useful data to evaluate the relationship between T. gondii infection and schizophrenia.
Materials and methods

Patients and control
In this study, 477 patients with schizophrenia were selected from the patients in the 3rd people's hospital, Zhaoqing, Guangdong province, P.R. China. The Structured Clinical Interview for "Diagnostic and Statistical Manual of Mental Disorders, 4th Edition" (DSM-IV) was used for clinical diagnosis. All patients had no family history of schizophrenia, no history of head trauma, brain surgery, previous meningitis/encephalitis or history of alcoholism. The patients were also not immunodeficient and did not have other immunological abnormalities, preexisting medical conditions, neurological diseases, or other substance abuse. In addition, the patients were asked to complete a short questionnaire on risky eating habits (repeated consumption of raw or undercooked meat) and contact with cats (present or previous cat ownership, cat in the same household, playing closely with cats, cleaning cat litter, etc). The age range of schizophrenia patients was from 16-48 (mean, 29.86 ± 5.99 ), the number of female patients was 229 (48.0%), and males 248 (52.0%). The control group was consisted of 210 blood donors, which selected from blood station of Guangzhou, Guangdong province, P.R. China, and did not have any physical or mental disorders according to the rules of blood donation. The age range was from 18-45 (mean, 28.12 ± 4.63), the number of female donors was 102 (48.6%), and males 108 (51.4%). They were similarly matched with the schizophrenia patient group with respect to age and gender.
The detection of antibodies
The measurements of immunoglobulin G (IgG) and M (IgM) to T. gondii were performed using enzyme linked immunosorbent assay (ELISA). A 96-well plate was coated with soluble tachyzoite antigens (STAg) of T. gondii RH strain, rSAG1 or rBAG1 at 1 μg/well overnight at 4°C and then was blocked with 1% newborn bovine serum and 0.05% Tween 20 in PBS at room temperature for 1 h. The plate was then washed three times with 0.05% Tween 20 in PBS. One hundred microliters of serum to be assayed (diluted 1:100 with 1% newborn bovine serum in PBS) were added to each well and were incubated at room temperature for 1 h. After washCombination of rSAG1 and rBAG1 antigens in the diagnosis of T. gondii in schizophrenia patients 355 ing with buffer (20 mM Tris-HCl pH 7.4, 500 mM NaCl, 0.05% Tween 20), each well was incubated with 100 μl of goat anti-human IgG or IgM HRP-conjugated secondary antibody at room temperature for 1 h. Following three washes of the step mention above, 100 μl of TMB (tetramethylbenzidine) substrate was added and left to incubate for 10 min. Color development was stopped by adding 50 μl of 2 M H 2 SO 4 to each well and the absorbance at 450 nm was measured with a Microreader (Model 550, Bio-Rad).
A total of 477 serum samples from schizophrenia patients and 210 samples from blood donors were tested by the ELISA mentioned above. Results were determined for each serum sample by calculating the mean value of the optimal density (OD) reading for duplicate wells. A positive result was estimated as any value higher than the average OD reading plus three standards deviations (cutoff) obtained with 30 sera from the negative control group.
Statistics
All statistical analyses were carried out with a Statistical Package for Social Sciences (SPSS version 13.0 for Windows). All tests were two-sided, and the significance was accepted at the 5% level. The categorical variables including the sera reactivity to T. gondii, history of eating raw meat or contact with cats, and the sera reactivity of schizophrenia patients and blood donors to both of rBAG1 and rSAG1 antigens were compared by use of the Chi-square test. In addition, odds ratio (OR) and the 95% CI were calculated. The reactivity to rBAG1, rSAG1 and STAg of the 477 schizophrenia patients' sera were compared by use of Matching Chi-square test (McNemer test) and coefficient κ test. A value of P<0.05 was considered statistically significantly.
Results
Analysis of the anti-T. gondii antibodies, by ELISA, based on three diagnostic antigens in 477 cases of Chinese people with schizophrenia
We analyzed the anti-T. gondii antibodies by ELISA as described above. Table I displays the ELISA results in the Chinese schizophrenia patients for both the rSAG1 and rBAG1 antigens. A significant association in the reactivity of the rBAG1 and rSAG1 to the schizophrenia patients's sera was found (P = 0.021) although as proportion of situations arose where sera were positive for one antibody but not the other. When rSAG1 was used as the antigen to detect the serum IgG from schizophrenia patients, 56 (of them, 16 were negative for rBAG1) samples were positive and 421 were negative; while rBAG1 was used as antigen for detection, 73 samples (of them, 33 were negative for rSAG1) were positive and 404 were negative. Among the 89 positive samples, 40 were positive for both rBAG1 and rSAG1. Table II indicates the comparison of antibodies detected in the Chinese schizophrenia patients using rBAG1 and STAg antigens by ELISA. A significant association in the reactivity between rBAG1 and STAg to the schizophrenia patients' sera was not observed (P = 0.111). When rBAG1 was used as the antigen to detect the sera from schizophrenia patients, 73 (of them, 35 were negative for STAg antigen) samples were positive and 404 were negative. When STAg was adopted as the antigen for detection, 60 samples (of them, 22 were negative for rBAG1) were positive and 417 were negative. Among the 95 positive samples, 38 shared the rBAG1 and STAg antigens. In addition, a significant association of the reactivity between rSAG1 and STAg to the Chinese schizophrenia patients' sera was also not detected (P = 0.665) (Table III) . When rSAG1 was used as the antigen to detect the serum from schizophrenia patients, 56 (of them, 22 were negative for STAg antigen) samples were positive and 421 were negative, while STAg was used as antigen for detection, 60 samples (of them, 26 were negative for The next question addressed was the association between the rSAG1 and rBAG1 to IgM antibodies of schizophrenia patients since they might be in the state of either acute/tachyzoite or chronic/bradyzoite infection of T. gondii. Table IV shows the association found between antibodies (IgM) in the Chinese schizophrenia patients using rSAG1 and rBAG1 antigens. A significant association between the reactivity of rBAG1 and rSAG1 to the schizophrenia patients' sera IgM was not demonstrated (P = 0.099). When SAG1 was used as the antigen to detect the sera IgM from schizophrenia patients, 49 (of them, 20 were negative for rBAG1) samples were positive and 428 were negative. Similarly, adopting rBAG1 as antigen for detection revealed that 39 samples (of them, 10 were negative for rSAG1) were positive and 438 were negative. Among the 59 positive (for IgM) samples, 29 shared both BAG1 and rSAG1 antigens. Table V indicates the difference of antibodies (IgM) in the Chinese schizophrenia patients against rBAG1 and STAg antigens by ELISA. A significant association between the reactivity of the rBAG1 and STAg to the schizophrenia patients's sera was found (P = 0.001). When rBAG1 was used as the antigen to detect the serum from the schizophrenia patients, 39 samples were positive (of them, 9 were negative for STAg antigen) and 438 were negative. However, when using STAg antigen for detection, 61 samples (of them, 31 were negative for rBAG1) were positive and 416 were negative. Among the 70 positive (for IgM) samples, 30 were shared between rBAG1 and STAg antigens. Similar results were also observed in rSAG1 and STAg antigens (Table VI) . A significant association in the reactivity to rSAG1 and STAg by the schizophrenia patients' sera was found (P = 0.023). When rSAG1 was used to detect the serum from schizophrenia patients, 43 (of them, 6 were negative for STAg antigen) samples were positive and 428 were negative, while, detection with STAg antigen resulted in, 61 positive samples (of them, 18 were negative for rSAG1) and 416 negative samples. Among the 67 positive (for IgM) samples, 43 were shared with rSAG1 and STAg/tachyzoite antigen.
Comparison of the antibodies anti-T. gondii between Chinese schizophrenia and blood donors
In recent studies, there is evidence suggesting that infection with T. gondii at the early stage of pregnancy may increase the risk for the development of schizophrenia in pregnant women. Table VII may support such an hypothesis. It reveals that in the 477 patients examined, 146 were confirmed to have regular habits of eating raw meat, while 242 patients had a history of contact with cats. A significant association in anti-T. gondii antibodies between the patients with and without history for eating raw meat was not observed (P = 0.163; OR = 1.902), but was apparent for anti-T. gondii antibodies between the patients with and without history of contact with cats (P = 0.010; OR = 2.207).
In addition, the correlation between schizophrenia and T. gondii infection has been of recent interest for many scientists. Here, our results also indicate that schizophrenia has a strong positive correlation with the sero-positivity for T. gondii infection (P<0.001) (Table VIII) . Seropositivity for T. gondii infection was significantly higher in the Chinese schizophrenia patients than the healthy control donors, both using rBAG1 and rSAG1 antigen (P<0.001). The seropositivity (including IgG and IgM) to STAg in 477 schizophrenia patients examined was 23.5% (112/477), in which sero-positivity for both rSAG1 and rBAG1 was 20.5% (98/477), while sero-positive to rSAG1, rBAG1 and STAg in blood donors were only 5.7% (12/210), 6.2% (13/210) and 5.7% (12/210), respectively. 
Discussion
Toxoplasma gondii infects a wide range of warm-blooded vertebrates, including birds, livestock, pets (particularly cats) and humans (Boothroyd 2009 ). In the life cycle of T. gondii, two forms, tachyzoite and bradyzoite, are found in infected humans and other mammalian intermediate hosts. These two forms are usually infective at different stages, although the mechanism of the conversion between tachyzoite and bradyzoite is unclear (Fouts and Boothroyd 2007) . In each form, however, there is expression of some stage-specific antigens, for instance, SAG1 is only expressed in the tachyzoite, while BAG1 is only found in bradyzoite (Kim and Boothroyd 2005, Saeij et al. 2005) .
To date, most of the commercial or self-made (non commercial) diagnostic kits for T. gondii infection are based on soluble tachyzoite antigens (STAg) of T. gondii RH strain. Obviously, there is a lack of one based on the SAG1 or BAG1 antigens, which are stage specific for tachyzoite and bradyzoite stages, respectively. It would be very useful to compare the difference between the STAg and BAG1 or SAG1 when they are used for the detection of T. gondii infection. We are particularly interested in the serum samples from schizophrenia patients.
By comparison of the IgG antibody reaction with the rBAG1 and rSAG1 by ELISA in schizophrenia serum samples (Table I) , results indicate that beside the cases which can be detected by both rSAG1 and rBAG1, some sero-positivity for T. gondii in schizophrenia sera can only be detected either by recombinant SAG1 or rBAG1. This phenomenon was also observed in the detection of IgM with rSAG1 and rBAG1 (Tables IV, V and VI). Therefore, we suggest that T. gondii infection in schizophrenia patients may have at least three types: tachyzoite-dominant infection, bradyzoite-dominant infection and dual dominant infection. Furthermore, the different infective type/form implies the different infective stage of T. gondii. This is important for the epidemiological study of T. gondii infection and more precise analysis/diagnosis of the infection could provide very useful information for control and treatment of this parasite. In subsequent studies, more samples from the patients and more experiments should be carried out on this topic.
Based on our results, the combined use of recombinant SAG1 and rBAG1 antigens in the diagnosis of T. gondii infection could provide a more accurate indication of infection regarding this parasite in schizophrenia patients. Although STAg can also be used as the diagnosis of T. gondii infection from the schizophrenia patients, it may not actually indicate the infection as some positive samples may be mistakenly considered to be negative (Tables II, III, V and VI) . It is clear that more specific antigens from tachyzoites, bradyzoites, or even from the cyst "wall" proteins of different genotype strains of T. gondii should be considered to be used for the development of diagnostic kits for the detection of T. gondii infection. An increase in the number of samples from the schizophrenia patients should also be carried out in future work.
It is well known that felines are the only definitive hosts of T. gondii and the infected cat produces a large number of oocysts that can easily contaminate food and the environment. Therefore, cats play a most important role for the transmission of T. gondii among the mammalian hosts including humans (Dubey 2009) . A large body of evidence worldwide indicates that higher sero-positivity for T. gondii is found in populations that have had a previous history of contact with cats (Torrey and Yolken 2003 , Torrey et al. 2007 . Our results also demonstrate that the sero-positive rate for T. gondii in the Chinese schizophrenia patients with history for contact with cats is higher than those patients without such contacting history with cat (with OR rate at 2.207, see Table VII ). Although we do not have the related information in our current study, it is possible that schizophrenia patients may have more chance of acquiring infection than normal healthy individuals, as their hygienic standards and conditions can often be neglected. As a matter of fact, our results also show that the sero-positive rate for T. gondii in the Chinese schizophrenia patients was higher than that in the blood donors (Table VIII) . However, studies have indicated that sero-positivity for T. gondii infection in newborn babies will have a higher risk for the development of schizophrenia than those that are negative for T. gondii, which provides evidence to show a strong link between congenital T. gondii infection and the onset schizophrenia in particular (Brown et al. 2005 , Lafferty 2006 , Mortensen et al. 2007 , Tamer et al. 2008 ). Although we do not have such results for the longterm investigation in Chinese populations, it will be valuable to assess this information to get a better understanding of the relationship between T. gondii infection and schizophrenia in the Chinese population.
In conclusion, our results further confirm a relationship between T. gondii sero-positivity and schizophrenia. More importantly, our results provide evidence that the combination of rSAG1 and rBAG1 antigens in the diagnosis of T. gondii infection could closely reflect the actual infection of this parasite in patients. Therefore, the development of a sensitive and specific diagnosis method based on the specific protein(s) from T. gondii would be one of the most important steps.
